Published in World J Mens Health on April 23, 2013
Wnt signaling in castration-resistant prostate cancer: implications for therapy. Am J Clin Exp Urol (2014) 0.93
Abnormal expression of CDK11p58 in prostate cancer. Cancer Cell Int (2014) 0.79
CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Oncotarget (2016) 0.78
Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists. PLoS One (2015) 0.75
Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications. Mol Cell Biol (2016) 0.75
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol (2008) 18.54
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene (1999) 3.95
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res (2000) 2.44
Linking beta-catenin to androgen-signaling pathway. J Biol Chem (2002) 2.27
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog (1991) 1.95
Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer (2004) 1.90
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res (2009) 1.89
Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol (2003) 1.56
Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer. Cancer Res (2008) 1.55
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J Clin Oncol (2005) 1.54
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. Clin Cancer Res (2003) 1.52
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest (2008) 1.30
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol (2005) 1.26
The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. BMC Cell Biol (2008) 1.21
Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer. J Urol (2002) 1.06
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer. Cancer Sci (2010) 1.05
Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells. Exp Cell Res (2009) 1.03
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate. J Urol (1998) 0.98
Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? Am J Pathol (2010) 0.95
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer. Dig Dis Sci (2002) 0.91
E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer. APMIS (2009) 0.85
FACT facilitates transcription-dependent nucleosome alteration. Science (2003) 5.83
Factors determining functional outcomes after radical prostatectomy: robot-assisted versus retropubic. Eur Urol (2011) 3.05
Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol (2005) 2.72
Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett (2006) 2.24
The mental health workforce gap in low- and middle-income countries: a needs-based approach. Bull World Health Organ (2010) 2.08
Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling. PLoS One (2008) 1.86
Incidence of port-site hernias after robot-assisted radical prostatectomy with the fascial closure of only the midline 12-mm port site. J Endourol (2012) 1.67
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance. Urology (2013) 1.63
Prevalence and associated factors of overactive bladder in Korean children 5-13 years old: a nationwide multicenter study. Urology (2008) 1.56
Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mL. Urology (2010) 1.48
Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy. Can J Urol (2014) 1.40
EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clin Cancer Res (2011) 1.33
Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun (2008) 1.20
Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. Mol Pharmacol (2006) 1.16
Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin II by H2O2 in red blood cells. Antioxid Redox Signal (2010) 1.15
A four-gene signature predicts disease progression in muscle invasive bladder cancer. Mol Med (2011) 1.14
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Oncotarget (2014) 1.13
Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Int J Oncol (2012) 1.12
Protein-kinase-C-mediated beta-catenin phosphorylation negatively regulates the Wnt/beta-catenin pathway. J Cell Sci (2006) 1.12
HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int J Cancer (2013) 1.11
Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis (2011) 1.10
Amplification of an RNA ligase ribozyme under alternating temperature conditions. FEBS Lett (2008) 1.09
Functional and oncologic outcomes comparing interfascial and intrafascial nerve sparing in robot-assisted laparoscopic radical prostatectomies. J Endourol (2009) 1.06
Penile abscess secondary to neglected penile fracture after intracavernosal vasoactive drug injection. World J Mens Health (2012) 1.05
The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem (2002) 1.05
Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB. FEBS Lett (2005) 0.99
Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J Biol Chem (2002) 0.97
Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation. Cell Res (2011) 0.97
Effect of bone morphogenetic protein-6 on macrophages. Immunology (2008) 0.95
Anti-asthmatic effect of marine red alga (Laurencia undulata) polyphenolic extracts in a murine model of asthma. Food Chem Toxicol (2008) 0.95
Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells. Exp Mol Med (2011) 0.94
Change in penile length in children: preliminary study. Korean J Urol (2012) 0.94
Hepatitis B virus X (HBX) protein upregulates β-catenin in a human hepatic cell line by sequestering SIRT1 deacetylase. Oncol Rep (2012) 0.94
Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur J Pharmacol (2007) 0.94
Effect of dominant negative transforming growth factor-beta receptor type II on cytotoxic activity of RAW 264.7, a murine macrophage cell line. Cancer Res (2007) 0.93
Cardamonin suppresses melanogenesis by inhibition of Wnt/beta-catenin signaling. Biochem Biophys Res Commun (2009) 0.93
Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels. J Korean Med Sci (2011) 0.92
Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells. Proc Natl Acad Sci U S A (2004) 0.92
Stimulation of protein kinase C-alpha suppresses colon cancer cell proliferation by down-regulation of beta-catenin. J Cell Mol Med (2009) 0.92
The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. Life Sci (2009) 0.91
The role of the Ser/Thr cluster in the phosphorylation of PPPSP motifs in Wnt coreceptors. Biochem Biophys Res Commun (2009) 0.91
[Construction of an explanatory model of female sexual dysfunction]. Taehan Kanho Hakhoe Chi (2007) 0.91
BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Cancer Res (2013) 0.90
Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-kappaB, ERK1/2, and p38 kinase. Eur J Pharmacol (2007) 0.90
Induction of interleukin-6 expression by bone morphogenetic protein-6 in macrophages requires both SMAD and p38 signaling pathways. J Biol Chem (2010) 0.90
Clavien classification of complications after the initial series of robot-assisted radical prostatectomy: the Cancer Institute of New Jersey/Robert Wood Johnson Medical School experience. J Endourol (2010) 0.89
Selection of an antiviral RNA aptamer against hemagglutinin of the subtype H5 avian influenza virus. Nucleic Acid Ther (2011) 0.89
SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin. Biochem Biophys Res Commun (2012) 0.88
Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans. Asian Pac J Cancer Prev (2014) 0.87
Analysis of the late outcome of laparoscopic heminephrectomy in children with duplex kidneys. BJU Int (2009) 0.87
Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells. PLoS One (2012) 0.87
Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion. Prostate (2013) 0.86
Oregon's experiment in health care delivery and payment reform: coordinated care organizations replacing managed care. J Health Polit Policy Law (2014) 0.86
CK1ε targets Cdc25A for ubiquitin-mediated proteolysis under normal conditions and in response to checkpoint activation. Cell Cycle (2011) 0.85
Changes to the electronic health records market in light of health information technology certification and meaningful use. J Am Med Inform Assoc (2012) 0.85
Transitions between the public mental health system and jail for persons with severe mental illness: a Markov analysis. Health Econ (2006) 0.85
The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Res Clin Pract (2008) 0.85
Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer. Clin Genitourin Cancer (2012) 0.85
Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients. Yonsei Med J (2005) 0.85
Biochemical and functional characterization of alpha-adrenergic receptors in the rabbit vagina. Life Sci (2002) 0.85
Comparative assessment of a single surgeon's series of laparoscopic radical prostatectomy: conventional versus robot-assisted. J Endourol (2011) 0.84
Pathological findings following radical prostatectomy in patients who are candidates for active surveillance: impact of varying PSA levels. Asian J Androl (2011) 0.84
Oregon's coordinated care organizations: a promising and practical reform model. J Health Polit Policy Law (2014) 0.84
Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev (2013) 0.84
Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation. Mol Pharmacol (2011) 0.84
Pharmacokinetics, pharmacodynamics and clinical efficacy of abiraterone acetate for treating metastatic castration-resistant prostate cancer. Expert Opin Drug Metab Toxicol (2015) 0.84
Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH. Ann Surg Oncol (2014) 0.84
Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer. PLoS One (2010) 0.83
Disasters and the public health safety net: Hurricane Floyd hits the North Carolina Medicaid program. Am J Public Health (2003) 0.83
Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop. Prostate (2011) 0.83
Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1. Toxicol In Vitro (2006) 0.83
Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells. Int J Oncol (2009) 0.83
Pathologic implications of prostatic anterior fat pad. Urol Oncol (2011) 0.83
Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin. Mol Pharmacol (2007) 0.83
Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13. Nucleic Acids Res (2010) 0.82
Incidence of upgrading and upstaging in patients with low-volume Gleason score 3+4 prostate cancers at biopsy: finding a new group eligible for active surveillance. Urol Int (2013) 0.82
Early experience with hyaluronic Acid instillation to assist with visual internal urethrotomy for urethral stricture. Korean J Urol (2010) 0.82
Murrayafoline A attenuates the Wnt/beta-catenin pathway by promoting the degradation of intracellular beta-catenin proteins. Biochem Biophys Res Commun (2009) 0.82
Cardamonin suppresses the proliferation of colon cancer cells by promoting β-catenin degradation. Biol Pharm Bull (2013) 0.82
Isoreserpine promotes beta-catenin degradation via Siah-1 up-regulation in HCT116 colon cancer cells. Biochem Biophys Res Commun (2009) 0.82
Impact of adjuvant androgen-deprivation therapy on disease progression in patients with node-positive prostate cancer. Korean J Urol (2011) 0.82
GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer. J Korean Med Sci (2011) 0.81
Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril (2002) 0.81
Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy. J Endourol (2013) 0.81
Effective isolation of magnesium lithospermate B and its inhibition of aldose reductase and fibronectin on mesangial cell line. Chem Pharm Bull (Tokyo) (2002) 0.81
DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cells. Ann Surg Oncol (2014) 0.81
Tissue hOGG1 genotype predicts bladder cancer prognosis: a novel approach using a peptide nucleic acid clamping method. Ann Surg Oncol (2010) 0.81
Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats. J Gene Med (2005) 0.81
CREBZF, a novel Smad8-binding protein. Mol Cell Biochem (2012) 0.81
RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer. J Surg Oncol (2011) 0.81